Skip to main content
Top
Published in: BMC Nephrology 1/2017

Open Access 01-12-2017 | Research article

Symptom burden in chronic kidney disease; a population based cross sectional study

Authors: Sameera Senanayake, Nalika Gunawardena, Paba Palihawadana, Palitha Bandara, Rashan Haniffa, R Karunarathna, Priyantha Kumara

Published in: BMC Nephrology | Issue 1/2017

Login to get access

Abstract

Background

Physical and psychological symptoms are among main manifestations of Chronic Kidney Disease (CKD). This study aimed to assess the symptom burden and self-perceived severity of symptoms among CKD patients living in a district in Sri Lanka.

Method

A community based cross-sectional study included a sample of randomly selected 1174 CKD patients from all 19 Medical Officer of Health areas in the district of Anuradhapura. Trained para-medical staff visited the households and administered the locally validated questionnaire to assess the presence and severity of symptoms. The inquiry was on 25 symptoms in a 5 point Likert scale indicating the severity during the previous week. Symptom burden score was constructed by summing each symptom severity score which ranged from 0 to 125.

Results

A total of 1118 CKD patients participated with a response rate of 95.2%. The mean age was 58.3 (SD 10.8) years and 62.7% were males. A majority were in CKD stage 4 (58.3%). Bone/joint pain was the most experienced symptom (87.6%; 95%CI 85.6–89.5). Loss of libido was the most severe symptom. The median symptom burden score was 35.0 (IQR 20.0–50.0). Multiple linear regression revealed education up to Advanced Level (β −9.176), CKD stage V (β 3.373), being dialyzed (β 20.944), comorbidities (β 4.241) and being employed (β −9.176) to be significant predictors of symptom burden.

Conclusions

Patients in all stages of CKD experience high symptom burden warranting rigorous measures to relieve symptoms and to improve the well-being of CKD patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int. 2005;68(s98):S7–10.CrossRef Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int. 2005;68(s98):S7–10.CrossRef
2.
go back to reference Wesseling C, Crowe J, Hogstedt C, Jakobsson K, Lucas R, Wegman D. Mesoamerican nephropathy: report from the first international research workshop on men. SALTRA/IRET-UNA; 2013; Wesseling C, Crowe J, Hogstedt C, Jakobsson K, Lucas R, Wegman D. Mesoamerican nephropathy: report from the first international research workshop on men. SALTRA/IRET-UNA; 2013;
5.
go back to reference Anderson H, Ward C, Eardley A, Gomm SA, Connolly M, Coppinger T, et al. The concerns of patients under palliative care and a heart failure clinic are not being met. Palliat Med. 2001;15(4):279–86.CrossRefPubMed Anderson H, Ward C, Eardley A, Gomm SA, Connolly M, Coppinger T, et al. The concerns of patients under palliative care and a heart failure clinic are not being met. Palliat Med. 2001;15(4):279–86.CrossRefPubMed
6.
go back to reference Tranmer JE, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Coulson K. Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale. J Pain Symptom Manag Elsevier. 2003;25(5):420–9.CrossRef Tranmer JE, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Coulson K. Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale. J Pain Symptom Manag Elsevier. 2003;25(5):420–9.CrossRef
7.
go back to reference Sepúlveda C, Marlin A, Yoshida T, Ullrich A. Palliative care: the World Health Organization’s global perspective. J Pain Symptom Manag. 2002;24(2):91–6.CrossRef Sepúlveda C, Marlin A, Yoshida T, Ullrich A. Palliative care: the World Health Organization’s global perspective. J Pain Symptom Manag. 2002;24(2):91–6.CrossRef
8.
go back to reference Weisbord SD, Fried LF, Arnold RM, Rotondi AJ, Fine MJ, Levenson DJ, et al. Development of a symptom assessment instrument for chronic hemodialysis patients: the dialysis symptom index. J Pain Symptom Manag. 2004;27(3):226–40.CrossRef Weisbord SD, Fried LF, Arnold RM, Rotondi AJ, Fine MJ, Levenson DJ, et al. Development of a symptom assessment instrument for chronic hemodialysis patients: the dialysis symptom index. J Pain Symptom Manag. 2004;27(3):226–40.CrossRef
9.
go back to reference Murphy EL, Murtagh FEM, Carey I, Sheerin NS. Understanding symptoms in patients with advanced chronic kidney disease managed without dialysis: use of a short patient-completed assessment tool. Nephron Clin Pract. 2009;111(1):c74–80.CrossRefPubMed Murphy EL, Murtagh FEM, Carey I, Sheerin NS. Understanding symptoms in patients with advanced chronic kidney disease managed without dialysis: use of a short patient-completed assessment tool. Nephron Clin Pract. 2009;111(1):c74–80.CrossRefPubMed
10.
go back to reference Senanayake SJ, Gunawardena N, Palihawadana P. Development of the chronic kidney disease symptom index – Sri Lanka; a symptom assessment instrument for chronic kidney disease patients. J Postgrad Inst Med. 2017;4(1):E38 1–12. Senanayake SJ, Gunawardena N, Palihawadana P. Development of the chronic kidney disease symptom index – Sri Lanka; a symptom assessment instrument for chronic kidney disease patients. J Postgrad Inst Med. 2017;4(1):E38 1–12.
11.
go back to reference Almutary H, Bonner A, Douglas C. Review article symptom burden in chronic kidney disease. In: A review of recent literature; 2013. p. 140–51. Almutary H, Bonner A, Douglas C. Review article symptom burden in chronic kidney disease. In: A review of recent literature; 2013. p. 140–51.
12.
go back to reference Almaguer M, Herrera R, Orantes CM. Chronic kidney disease of unknown etiology in agricultural communities. MEDICC Rev. 2014;16(2):9–15.PubMed Almaguer M, Herrera R, Orantes CM. Chronic kidney disease of unknown etiology in agricultural communities. MEDICC Rev. 2014;16(2):9–15.PubMed
14.
go back to reference Weisbord SD. Symptoms and their correlates in chronic kidney disease. Adv Chronic Kidney Dis. 2007;14(4):319–27.CrossRefPubMed Weisbord SD. Symptoms and their correlates in chronic kidney disease. Adv Chronic Kidney Dis. 2007;14(4):319–27.CrossRefPubMed
15.
go back to reference Petrie KJ, Weinman J. Why illness perceptions matter. Clin Med J R Coll Physicians London. 2006;6(6):536–9. Petrie KJ, Weinman J. Why illness perceptions matter. Clin Med J R Coll Physicians London. 2006;6(6):536–9.
16.
go back to reference Hagger MS, Orbell S. A meta-analytic review of the common-sense model of illness representations. Psychol Heal Taylor Francis. 2003;18(2):141–84.CrossRef Hagger MS, Orbell S. A meta-analytic review of the common-sense model of illness representations. Psychol Heal Taylor Francis. 2003;18(2):141–84.CrossRef
17.
go back to reference Winkleby MA, Jatulis DE, Frank E, Fortmann SP. Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Health. 1992;82(6):816–20.CrossRefPubMedPubMedCentral Winkleby MA, Jatulis DE, Frank E, Fortmann SP. Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Health. 1992;82(6):816–20.CrossRefPubMedPubMedCentral
18.
go back to reference Adler NE, Ostrove JM. Socioeconomic status and health: what we know and what we don’t. Ann N Y Acad Sci. Wiley Online Library. 1999;896(1):3–15.CrossRefPubMed Adler NE, Ostrove JM. Socioeconomic status and health: what we know and what we don’t. Ann N Y Acad Sci. Wiley Online Library. 1999;896(1):3–15.CrossRefPubMed
Metadata
Title
Symptom burden in chronic kidney disease; a population based cross sectional study
Authors
Sameera Senanayake
Nalika Gunawardena
Paba Palihawadana
Palitha Bandara
Rashan Haniffa
R Karunarathna
Priyantha Kumara
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2017
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-017-0638-y

Other articles of this Issue 1/2017

BMC Nephrology 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.